The objective of the pragmatic trial to test the effectiveness of an existing, ongoing clinical service, the VA National TeleOncology program (NTO), a multilevel telehealth population health management program. The primary aims are to study the intervention and determine its effectiveness on telehealth engagement, clinical quality, and healthcare cost outcomes across personal characteristics.
A Veteran
Aged 18 years or older
Newly diagnosed with lung, prostate, breast, or colon cancer within 3 months of telemedicine visit
Engaged in an oncology visit during the 36-month analysis period at a Veterans Affairs Medical Center (VAMC) location.
Veterans who have not seen any providers in the VA within the past year
Patients previously diagnosed with lung, prostate, breast, or colon cancer
Pregnant patients
NYU Langone Health
Lead sponsor
National Cancer Institute (NCI)
Collaborator